Suchergebnisse - "Uemura, Hayato"

PubPharm (16)

1

Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2024

von Yamada, S. | Uchida, Y. | Kouyama, J. | +9

2

Significance of portal venous blood flow as a factor to determine liver function in patients with decompensated cirrhosis due to hepatitis C virus infection following achievement of sustained viral response by sofosbuvir plus velpatasvir

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2023

von Uchida, Y. | Imai, Y. | Tsuji, S. | +10

3

Significance of furosemide in patients with cirrhosis treated with or without zinc acetate hydrate supplementation

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2022

von Uchida, Y. | Uemura, H. | Tsuji, S. | +9

4

Superiority of tenofovir alafenamide fumarate over entecavir for serum HBsAg level reduction in patients with chronic HBV infection : A 144-week outcome study after switching of the nucleos(t)ide analog

enthalten in: PloS one | 2022

von Uchida, Y. | Nakao, M. | Yamada, S. | +9

5

Nationwide survey for patients with acute-on-chronic liver failure occurring between 2017 and 2019 and diagnosed according to proposed Japanese criteria

enthalten in: Journal of gastroenterology | 2021

von Nakayama, N. | Uemura, H. | Uchida, Y. | +21

6

Porphyromonas gingivalis induces entero-hepatic metabolic derangements with alteration of gut microbiota in a type 2 diabetes mouse model

enthalten in: Scientific reports | 2021

von Kashiwagi, Y. | Aburaya, S. | Sugiyama, N. | +14

ErratumIn: Sci Rep. 2021 Oct 4;11(1):20016. - PMID 34608253

7

Aberrant splicing isoforms detected by full-length transcriptome sequencing as transcripts of potential neoantigens in non-small cell lung cancer

enthalten in: Genome biology | 2021

von Oka, M. | Xu, L. | Suzuki, T. | +9

8

Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2020

von Uchida, Y. | Inao, M. | Tsuji, S. | +9

9

Significance of liver dysfunction associated with decreased hepatic CT attenuation values in Japanese patients with severe COVID-19

enthalten in: Journal of gastroenterology | 2020

von Uchida, Y. | Uemura, H. | Yamaba, S. | +4

10

Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2020

von Uchida, Y. | Tsuji, S. | Uemura, H. | +9